FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2187550113> ?p ?o ?g. }

• W2187550113 endingPage "2695" @default.
• W2187550113 startingPage "2695" @default.
• W2187550113 abstract "Abstract Abstract 2695 Background: Age and cytogenetics are major determinants of outcome in older patients with AML. Complete response (CR) to induction chemotherapy is observed in less than half of de novo AML patients (excluding APL) older than 60 years. Because unfavorable treatment results are often obtained despite intensive chemotherapy, which carries the potential for significant treatment-induced morbidity and mortality, it would be valuable to be able to predict with high accuracy at the individual patient level who will achieve a CR. Prospective identification of patients unlikely to benefit from anthracycline/cytarabine-based chemotherapy could spare patients from unnecessary treatment-related toxicities and allow consideration for alternative therapeutic strategies. Single Cell Network Profiling (SCNP) is used to measure simultaneously the effects of multiple modulators (including drugs) on signaling cascades at the single cell level. Using SCNP technology we have developed a set of classifiers that predict for likelihood of response to anthracycline/cytarabine-based induction therapy in older patients with AML. Methods: SCNP assays were performed on paired, bone marrow (BM) and peripheral blood (PB), samples from 44 AML patients (de novo, evolved from an antecedent MDS or MPN or treatment related), >60 years old, enrolled on ECOG trial E3999. Based on two previous training studies, 38 combinations of modulators and intra-cellular proteins (signaling nodes along the phosphoinositide 3-kinase (P13K ), the Janus Kinases (Jak) signal transducers and activators of transcription (Stat) and the DNA damage response and apoptosis pathways) were investigated. Basal and modulated protein levels and the effect of modulation on proteins levels in the leukemic blast cells were expressed using a variety of metrics. A total of 64 node/metric combinations (dimensions) were used to build multi-parametric classifiers (ranging from 2 to 10 nodes/metrics) using different modeling methodologies (including random forest, boosting, lasso and a bootstrapped best subsets logistic modeling approach that shrinks regression coefficients (BBLRS)) able to predict the likelihood of response to induction therapy. The performance characteristics of the classifiers built on the BM samples were then evaluated independently on the paired PB samples. Results: Several promising models with high area under the operator/receiver curve (AUROC) values (indicating strong agreement between actual clinical responses and responses as predicted by the model) were developed based on SCNP proteomic read outs for BM samples. The observed and predicted values from the current best BBLRS model are shown in Figure 1. The unadjusted AUROC of this model is 0.98 and the expected AUROC for the model when applied to an independent (validation) sample is 0.84. Five signaling nodes are represented in this model; they include nodes belonging to growth factor- induced survival pathways (PI3K, RAS/MAPK) as well as DNA damage response and apoptosis pathways. When the predictive accuracy of the lead SCNP classifier was compared to that of a model based on traditional clinical/molecular predictors (i.e. the combination of age, therapy-related AML, and karyotype) the adjusted AUROC of the SCNP classifier far surpassed that of the clinical predictors (adjusted AUROC=0.61 for clinical/molecular predictors vs. adjusted AUROC= 0.84 for the SCNP classifier). Finally, when the nodes in the best BBLRS model developed on data from BM samples were used to model read outs from the paired PB samples, the adjusted AUROC of the resulting BBLRS model was comparable to that of the model fit to BM samples. Conclusion: This training set data show the value of performing quantitative SCNP under modulated conditions as the basis for developing highly predictive tests for response to induction chemotherapy. Most importantly, the predictions made by the SCNP classifier are independent of established prognostic factors, such as age and cytogenetics The ability of one set of nodes to accurately predict response in paired BM or PB samples from individual patients suggests that the predictive power of the SCNP assay is independent of sample source, further improving the practicality of the test. Independent validation studies are ongoing. Disclosures: Cesano: Nodality Inc.: Employment, Equity Ownership. Putta:Nodality Inc.: Employment, Equity Ownership. Gayko:Nodality Inc.: Employment, Equity Ownership. Hackett:Nodality Inc.: Consultancy. Rosen:Nodality Inc.: Employment, Equity Ownership." @default.
• W2187550113 created "2016-06-24" @default.
• W2187550113 creator A5001124933 @default.
• W2187550113 creator A5016061346 @default.
• W2187550113 creator A5050588157 @default.
• W2187550113 creator A5053257332 @default.
• W2187550113 creator A5054928899 @default.
• W2187550113 creator A5064012830 @default.
• W2187550113 creator A5064221788 @default.
• W2187550113 creator A5077058201 @default.
• W2187550113 creator A5078217584 @default.
• W2187550113 creator A5079511754 @default.
• W2187550113 creator A5085360755 @default.
• W2187550113 date "2010-11-19" @default.
• W2187550113 modified "2023-10-01" @default.
• W2187550113 title "Single-Cell Network Profiliing (SCNP) Signatures Independently Predict Response to Induction Therapy In Older Patients with Acute Myeloid Leukemia (AML)" @default.
• W2187550113 cites W140461218 @default.
• W2187550113 cites W2072778470 @default.
• W2187550113 cites W2139638366 @default.
• W2187550113 doi "https://doi.org/10.1182/blood.v116.21.2695.2695" @default.
• W2187550113 hasPublicationYear "2010" @default.
• W2187550113 type Work @default.
• W2187550113 sameAs 2187550113 @default.
• W2187550113 citedByCount "1" @default.
• W2187550113 countsByYear W21875501132012 @default.
• W2187550113 crossrefType "journal-article" @default.
• W2187550113 hasAuthorship W2187550113A5001124933 @default.
• W2187550113 hasAuthorship W2187550113A5016061346 @default.
• W2187550113 hasAuthorship W2187550113A5050588157 @default.
• W2187550113 hasAuthorship W2187550113A5053257332 @default.
• W2187550113 hasAuthorship W2187550113A5054928899 @default.
• W2187550113 hasAuthorship W2187550113A5064012830 @default.
• W2187550113 hasAuthorship W2187550113A5064221788 @default.
• W2187550113 hasAuthorship W2187550113A5077058201 @default.
• W2187550113 hasAuthorship W2187550113A5078217584 @default.
• W2187550113 hasAuthorship W2187550113A5079511754 @default.
• W2187550113 hasAuthorship W2187550113A5085360755 @default.
• W2187550113 hasConcept C104317684 @default.
• W2187550113 hasConcept C121608353 @default.
• W2187550113 hasConcept C126322002 @default.
• W2187550113 hasConcept C143998085 @default.
• W2187550113 hasConcept C150194340 @default.
• W2187550113 hasConcept C190727270 @default.
• W2187550113 hasConcept C2776611710 @default.
• W2187550113 hasConcept C2776694085 @default.
• W2187550113 hasConcept C2776802502 @default.
• W2187550113 hasConcept C2778041864 @default.
• W2187550113 hasConcept C2778336483 @default.
• W2187550113 hasConcept C2778729363 @default.
• W2187550113 hasConcept C2780235182 @default.
• W2187550113 hasConcept C530470458 @default.
• W2187550113 hasConcept C55493867 @default.
• W2187550113 hasConcept C71924100 @default.
• W2187550113 hasConcept C86803240 @default.
• W2187550113 hasConceptScore W2187550113C104317684 @default.
• W2187550113 hasConceptScore W2187550113C121608353 @default.
• W2187550113 hasConceptScore W2187550113C126322002 @default.
• W2187550113 hasConceptScore W2187550113C143998085 @default.
• W2187550113 hasConceptScore W2187550113C150194340 @default.
• W2187550113 hasConceptScore W2187550113C190727270 @default.
• W2187550113 hasConceptScore W2187550113C2776611710 @default.
• W2187550113 hasConceptScore W2187550113C2776694085 @default.
• W2187550113 hasConceptScore W2187550113C2776802502 @default.
• W2187550113 hasConceptScore W2187550113C2778041864 @default.
• W2187550113 hasConceptScore W2187550113C2778336483 @default.
• W2187550113 hasConceptScore W2187550113C2778729363 @default.
• W2187550113 hasConceptScore W2187550113C2780235182 @default.
• W2187550113 hasConceptScore W2187550113C530470458 @default.
• W2187550113 hasConceptScore W2187550113C55493867 @default.
• W2187550113 hasConceptScore W2187550113C71924100 @default.
• W2187550113 hasConceptScore W2187550113C86803240 @default.
• W2187550113 hasIssue "21" @default.
• W2187550113 hasLocation W21875501131 @default.
• W2187550113 hasOpenAccess W2187550113 @default.
• W2187550113 hasPrimaryLocation W21875501131 @default.
• W2187550113 hasRelatedWork W2016381406 @default.
• W2187550113 hasRelatedWork W2187550113 @default.
• W2187550113 hasRelatedWork W2416222060 @default.
• W2187550113 hasRelatedWork W2527530754 @default.
• W2187550113 hasRelatedWork W2552744145 @default.
• W2187550113 hasRelatedWork W2563690359 @default.
• W2187550113 hasRelatedWork W2979117532 @default.
• W2187550113 hasRelatedWork W3133176200 @default.
• W2187550113 hasRelatedWork W3216531775 @default.
• W2187550113 hasRelatedWork W4310103271 @default.
• W2187550113 hasVolume "116" @default.
• W2187550113 isParatext "false" @default.
• W2187550113 isRetracted "false" @default.
• W2187550113 magId "2187550113" @default.
• W2187550113 workType "article" @default.